CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-21 | Sheena Jonathan Director | Exercise or conversion 10b5-1 | +144 | 262,716 | ||
| 2025-01-21 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit 10b5-1 | −144 | 0 | ||
| 2025-01-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +644 | 239,832 | ||
| 2025-01-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −644 | 0 | ||
| 2025-01-21 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +1,775 | 346,182 | ||
| 2025-01-21 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,775 | 0 | ||
| 2025-01-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,145 | 135,596 | ||
| 2025-01-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,145 | 0 | ||
| 2025-01-20 | Sheena Jonathan Director | Exercise or conversion 10b5-1 | +191 | 262,572 | ||
| 2025-01-20 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit 10b5-1 | −191 | 761 | ||
| 2025-01-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +856 | 239,188 | ||
| 2025-01-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −856 | 3,424 | ||
| 2025-01-20 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +3,386 | 344,407 | ||
| 2025-01-20 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −3,386 | 13,544 | ||
| 2025-01-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,522 | 134,451 | ||
| 2025-01-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,522 | 6,087 | ||
| 2025-01-16 | Sheena Jonathan Director | Exercise or conversion | +3,043 | 257,415 | ||
| 2025-01-16 | Sheena Jonathan Director | Grant or award | +4,966 | 262,381 | ||
| 2025-01-16 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit | −3,043 | 0 | ||
| 2025-01-16 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion | +13,696 | 213,500 |
Page 58 of 85 · 1,682 trades